Clinical Trial Update: Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating safety and efficacy of LEO 80185 topical suspension in adolescents (12-17) with scalp psoriasis has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scalp Psoriasis

Drugs mentioned

• LEO 80185 Topical Suspension

Snippet

Sponsor: LEO Pharma | Conditions: Scalp Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2015-10-12